Detailed Information on Publication Record
2018
Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma
HANDL, Marek, Markéta HERMANOVÁ, Sylva HOTÁRKOVÁ, Jiří JARKOVSKÝ, Peter MÚDRY et. al.Basic information
Original name
Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma
Authors
HANDL, Marek (203 Czech Republic), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Sylva HOTÁRKOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Peter MÚDRY (203 Czech Republic, belonging to the institution), Tetiana SHATOKHINA (804 Ukraine, belonging to the institution), Marcela VESELA (203 Czech Republic), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Iva ZAMBO (203 Czech Republic, guarantor, belonging to the institution)
Edition
Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2018, 1213-8118
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.141
RIV identification code
RIV/00216224:14110/18:00104043
Organization unit
Faculty of Medicine
UT WoS
000428951000010
Keywords in English
tumor associated macrophages; Ewing sarcoma; immunohistochemistry; CD68; CD163; prognosis
Tags
International impact, Reviewed
Změněno: 9/2/2019 21:40, Soňa Böhmová
Abstract
V originále
Aims. Tumor-associated macrophages (TAMs) are known markers playing complex roles in tumorigenesis. However, the function of TAMs in a variety of malignancies is not yet fully understood. The aim of this pilot study was to quantify the density of TAMs in Ewing sarcoma and to determine the correlation between TAMs and clinicopathological parameters. Methods. Using immunohistochemistry, the expressions of CD68 and CD163 were examined in 24 tissue samples of Ewing sarcoma of bone. The density of CD68 and CD163-positive TAMs was analyzed quantitatively and semi-quantitatively and statistically correlated with clinical parameters. Results. CD163-positive TAMs outnumbered CD68-positive cells (median of 130 vs 96, respectively). No statistically significant relatio nship was found between density of CD68-positive cells, clinical parameters or prognosis. However, high levels of CD163-positive TAMs were associated with localized disease (P=0.008). In cases with a higher density of CD163-positive cells, a trend toward longer survival was revealed (P=0.063). Conclusion. This is the first study that has quantified CD163 expression in TAMs in Ewing sarcoma and showed its possible prognostic value. CD163 was confirmed to be a more specific marker of macrophages than CD68. CD163 is not an exclusive hallmark of M2 macrophages.
Links
MUNI/FR/0377/2014, interní kód MU |
|